Showing results (21-30 of 143) with videos related to
Sort By:
Pageof 15
Analytical Methods : Advancing Methods and Applications|July 1, 2025
Validated green ultra-fast UPLC-MS/MS method for the quantification of fedratinib in an HLM matrix: application to <i>in vitro</i> and <i>in silico</i> metabolic stability studiesMohamed W Attwa, Ali S Abdelhameed, Adnan A KadiRSC Advances|May 11, 2022
LC-ESI-MS/MS reveals the formation of reactive intermediates in brigatinib metabolism: elucidation of bioactivation pathwaysAdnan A Kadi, Mohamed W Attwa, Hany W DarwishMedicina (Kaunas, Lithuania)|October 26, 2024
An Ultra-Fast Green UHPLC-MS/MS Method for Assessing the In Vitro Metabolic Stability of Dovitinib: In Silico Study for Absorption, Distribution, Metabolism, Excretion, Metabolic Lability, and DEREK AlertsMohamed W Attwa, Ali S Abdelhameed, Adnan A KadiHeliyon|August 2, 2024
Characterization of the in vitro metabolic profile of nazartinib in HLMs using UPLC-MS/MS method: In silico metabolic lability and DEREK structural alerts screening using StarDrop softwareMohamed W Attwa, Ali S Abdelhameed, Adnan A KadiMedicina (Kaunas, Lithuania)|January 8, 2025
An Ultra-Fast Validated Green UPLC-MS/MS Approach for Assessing Revumenib in Human Liver Microsomes: In Vitro Absorption, Distribution, Metabolism, and Excretion and Metabolic Stability EvaluationMohamed W Attwa, Ali S Abdelhameed, Adnan A KadiJournal of Separation Science|August 1, 2024
An ultra-fast ultra-high-performance liquid chromatography-tandem mass spectrometry method for estimating the in vitro metabolic stability of palbociclib in human liver microsomes: In silico study for metabolic lability, absorption, distribution, metabolism, and excretion features, and DEREK alerts screeningMohamed W Attwa, Ali S Abdelhameed, Adnan A KadiDrug Design, Development and Therapy|December 10, 2020
Characterization of Stable and Reactive Metabolites of the Anticancer Drug, Ensartinib, in Human Liver Microsomes Using LC-MS/MS: An in silico and Practical Bioactivation ApproachAli S Abdelhameed, Mohamed W Attwa, Adnan A KadiJournal of Pharmaceutical and Biomedical Analysis|November 26, 2018
Reactive intermediates and bioactivation pathways characterization of avitinib by LC-MS/MS: In vitro metabolic investigationMohamed W Attwa, Adnan A Kadi, Ali S AbdelhameedRSC Advances|May 13, 2022
Characterization of reactive intermediates formation in dacomitinib metabolism and bioactivation pathways elucidation by LC-MS/MS: <i>in vitro</i> phase I metabolic investigationMohamed W Attwa, Adnan A Kadi, Ali S AbdelhameedBiomedical Chromatography : BMC|October 4, 2025
Evaluation of Anlotinib Metabolic Stability in HLMs Matrix Applying Ultra-Fast UPLC-MS/MS Approach: Greenness Assessment With In Silico Testing for Structural Alarms Related to the Metabolic Lability and DEREK ToxicityMohamed W Attwa, Ali S Abdelhameed, Adnan A KadiPageof 15